Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

0.37
Delayed Data
As of 12:04pm ET
 +0.025 / +7.25%
Today’s Change
0.30
Today|||52-Week Range
1.05
-26.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues296.0K715.0K424.0K139.0K
 
 
 
 
 
Depreciation And Amortization50.0K55.0K53.0K42.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses3.9M4.1M4.2M3.8M
 
 
 
 
 
Research And Development2.5M2.8M2.5M2.5M
 
 
 
 
 
Total Operating Expenses3.9M4.1M4.3M3.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.6M-3.4M-3.9M-3.7M
 
 
 
 
 
Extraordinary Charge-4.0K-27.0K--0.00
 
 
 
Other Expenses-133.0K232.0K-15.0K200.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.8M-3.2M-3.9M-3.5M
 
 
 
 
 
Income Taxes-405.0K-478.0K-498.0K-493.0K
 
 
 
 
 
Preferred Dividend-50.0K-50.0K-51.0K-50.0K
 
 
 
 
 
Net Income-3.3M-2.7M-3.4M-3.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS34.4M34.7M35.0M35.6M
 
 
 
 
 
Shares To Calculate EPS Diluted34.4M34.7M35.0M35.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.10-$0.08-$0.10-$0.09
 
 
 
 
 
EPS Diluted-$0.10-$0.08-$0.10-$0.09